Ferri Marica, Bargagli Anna Maria, Faggiano Fabrizio, Belleudi Valeria, Salamina Giuseppe, Vigna-Taglianti Federica, Davoli Marina, Perucci Carlo A
Agenzia di sanità pubblica della Regione Lazio, via di Santa Costanza 53, 00198 Roma.
Epidemiol Prev. 2007 Sep-Oct;31(5):276-82.
to describe the overall and cause-specific mortality among heroin users attending Public Treatment Centers (PTCs) in Italy and to estimate the impact of heroin use on mortality in the general population.
A cohort of 10,376 patients (8881 men and 1495 women) enrolled over a period of 18 months between september 1998 and september 2000 and followed-up through 31st of March 2001 (VEdeTTE study).
190 deaths occurred during the study period (153 men and 37 women): 70 deaths were due to overdose (36.8%), 38 to AIDS (20.0%), 30 to violence (15.8%). The direct standardized overall mortality rate per 1000 person/years is 12.0 (CI 95% 5.4-18.6): 12.7/1000 p-y (CI 95% 4.9-20.5) among males and 8.4/1000 p-y (95% CI 4.7-12.2) among females. This study confirms that overdose is the leading cause of death in heroin users (mortality rate 2.6/1000 p-y (95% CI 0.8-4.5) among males and 4.0/1000 p-y (95% CI 0.9-7.2) among females. AIDS mortality rates are 2.6/1000 p-y, 95% CI 0.6-4.6 among males and 1.8/1000 p-y (95% CI 0.4-3.1) among females. The mortality rate for all the other causes is 6.0/1000 p-y (95% CI 0.0-14.0) among males and 2.3/1000 p-y (95% CI 0.9-3.6) among females. The standardized mortality ratios for all causes in comparison to age and gender matched general population show the excess particularly important for females (SMR 6.7; 95% CI 5.7-7.8 for males and SMR 22.8; 95% CI 16.5-31.5 for females). The population attributable fraction highlights that 14.4% (95% IC 10.9-18.5) of deaths in people aged 30-34 in Italy in 2000 could be attributed to heroin addiction; the fraction decreases to 10.7% (95% CI 6.9-15.6) at age 25-29 and to 12.8% (95% CI 9.9-16.2) at age 35-39.
Mortality observed in this cohort is lower than that observed in previous studies, mainly due to reduction of AIDS and overdose mortality. The excess mortality over matched population is confirmed. Study population is older than in other studies (mean age at enrollment 31.1; DS 6.2); and the observation time is mainly spent in treatment. The mortality attributable faction shows that almost the 13% of deaths around the third decade of age can be attributed to drug dependence even though it is important to take into consideration the assumptions about drug addiction prevalence in the general population.
描述意大利公共治疗中心(PTCs)中使用海洛因者的总体死亡率和特定病因死亡率,并估计海洛因使用对普通人群死亡率的影响。
在1998年9月至2000年9月的18个月期间招募了10376名患者(8881名男性和1495名女性)组成队列,并随访至2001年3月31日(VEdeTTE研究)。
研究期间发生了190例死亡(153名男性和37名女性):70例死于过量用药(36.8%),38例死于艾滋病(20.0%),30例死于暴力(15.8%)。每1000人年的直接标准化总体死亡率为12.0(95%置信区间5.4 - 18.6):男性为12.7/1000人年(95%置信区间4.9 - 20.5),女性为8.4/1000人年(95%置信区间4.7 - 12.2)。本研究证实过量用药是海洛因使用者的主要死亡原因(男性死亡率为2.6/1000人年(95%置信区间0.8 - 4.5),女性为4.0/1000人年(95%置信区间0.9 - 7.2))。艾滋病死亡率男性为2.6/1000人年,95%置信区间0.6 - 4.6,女性为1.8/1000人年(95%置信区间0.4 - 3.1)。所有其他原因的死亡率男性为6.0/1000人年(95%置信区间0.0 - 14.0),女性为2.3/1000人年(95%置信区间0.9 - 3.6)。与年龄和性别匹配的普通人群相比,所有原因的标准化死亡比显示,女性的超额死亡率尤为显著(男性标准化死亡比为6.7;95%置信区间5.7 - 7.8,女性为22.8;95%置信区间16.5 - 31.5)。人群归因分数表明,2000年意大利30 - 34岁人群中14.4%(95%可信区间10.9 - 18.5)的死亡可归因于海洛因成瘾;在25 - 29岁时该比例降至10.7%(95%置信区间6.9 - 15.6),在35 - 39岁时降至12.8%(95%置信区间9.9 - 16.2)。
该队列中观察到的死亡率低于先前研究中的死亡率,主要归因于艾滋病和过量用药死亡率的降低。与匹配人群相比,超额死亡率得到了证实。研究人群比其他研究中的人群年龄更大(入组时平均年龄为31.1岁;标准差为6.2);且观察时间主要用于治疗。死亡率归因分数表明即使考虑到普通人群中海洛因成瘾患病率的假设,在三十岁左右几乎13%的死亡可归因于药物依赖。